Your browser doesn't support javascript.
loading
Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial.
Poddubnaya, Irina V; Alekseev, Sergey M; Kaplanov, Kamil D; Lukavetskyy, Les M; Rekhtman, Grigoriy B; Dolai, Tuphan K; Attili, V Satya Suresh; Bermúdez, Carlos D; Isaev, Aleksandr A; Chernyaeva, Ekaterina V; Ivanov, Roman A.
Afiliação
  • Poddubnaya IV; Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
  • Alekseev SM; Leningrad Regional Oncology Center, Saint Petersburg, Russia.
  • Kaplanov KD; Volgograd Regional Clinical Oncologic Dispensary, Volgograd, Russia.
  • Lukavetskyy LM; Hematology Department, Institute of Blood Pathology and Transfusion Medicine NAMS of Ukraine, Lviv, Ukraine.
  • Rekhtman GB; Hematology Department, Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine.
  • Dolai TK; Hematology Department, NRS Medical College and Hospital, Kolkata, India.
  • Attili VSS; Department of Internal Medicine, SVS Medical College, Mehabubnagar and Continental Hospitals, Hyderabad, India.
  • Bermúdez CD; CIOSAD Clinic and National Institute of Cancerology, Bogota, Colombia.
  • Isaev AA; JSC BIOCAD, Saint Petersburg, Russia.
  • Chernyaeva EV; JSC BIOCAD, Saint Petersburg, Russia.
  • Ivanov RA; JSC BIOCAD, Saint Petersburg, Russia.
Hematol Oncol ; 38(1): 67-73, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31724191

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Zona Marginal Tipo Células B / Medicamentos Biossimilares / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Zona Marginal Tipo Células B / Medicamentos Biossimilares / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article